版本:
中国

BRIEF-Medtronic initiates global trial evaluating cryoablation to treat persistent atrial fibrillation

March 30 Medtronic Plc:

* Medtronic initiates global trial evaluating cryoablation to treat persistent atrial fibrillation

* STOP Persistent AF is a prospective, multicenter, single-arm clinical trial that will enroll up to 225 patients at 25 centers Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐